Free Trial
NASDAQ:NLTX

Neoleukin Therapeutics (NLTX) Stock Price, News & Analysis

Neoleukin Therapeutics logo
$32.16 +3.13 (+10.78%)
As of 10/20/2025

About Neoleukin Therapeutics Stock (NASDAQ:NLTX)

Advanced

Key Stats

Today's Range
$29.01
$33.63
50-Day Range
$16.85
$34.37
52-Week Range
$2.03
$14.36
Volume
195,081 shs
Average Volume
50,104 shs
Market Capitalization
$302.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NLTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neoleukin Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NLTX Stock News Headlines

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
Robinhood warning
A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.tc pixel
Pre-market Movers: ORTX, CMBM, GROM, RSVR, FEMY…
Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
Neoleukin Therapeutics Recent Insider Activity
See More Headlines

NLTX Stock Analysis - Frequently Asked Questions

Neoleukin Therapeutics' stock was trading at $22.86 at the start of the year. Since then, NLTX shares have increased by 40.7% and is now trading at $32.16.

Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) posted its quarterly earnings results on Thursday, November, 4th. The company reported ($5.60) earnings per share for the quarter, hitting analysts' consensus estimates of ($5.60).

Neoleukin Therapeutics's stock reverse split on the morning of Tuesday, December 19th 2023.The 1-4 reverse split was announced on Tuesday, December 19th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Shares of NLTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neoleukin Therapeutics investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), GE Aerospace (GE) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
11/04/2021
Today
10/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NLTX
CIK
1404644
Employees
90
Year Founded
2019

Profitability

EPS (Trailing Twelve Months)
($3.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.56 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-37.22%
Return on Assets
-30.91%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.33
Quick Ratio
15.33

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$11.08 per share
Price / Book
2.62

Miscellaneous

Outstanding Shares
9,398,000
Free Float
9,250,000
Market Cap
$272.82 million
Optionable
No Data
Beta
1.11

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:NLTX) was last updated on 10/21/2025 by MarketBeat.com Staff
From Our Partners